Trial Profile
An exploratory study for clinical benefits of the guideline on drug use in subjects with pediatric obsessive compulsive disorder.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Fluvoxamine (Primary) ; Paroxetine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 23 Jan 2010 New trial record